Momenta, Sandoz Try To Pause Blood-Clot Drug Antitrust Suit

By Bryan Koenig · October 3, 2019, 6:27 PM EDT

Momenta and Sandoz have urged a Tennessee federal judge to pause a lawsuit accusing them of conspiring to monopolize blood-clot drug Lovenox and its generic version while they appeal the certification...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum in Support

Case Information

Case Title

The Hospital Authority of Metropolitan Government of Nashville and Davidson County, Tennessee v. Momenta Pharmaceuticals, Inc. et al

Case Number

Court

Tennessee Middle

Nature of Suit

Anti-Trust

Date Filed

October 14, 2015

Recent Articles By Bryan

April 08, 2025
Amedisys Gets Merger Filing Claim Paused In DOJ's UHG Suit
April 07, 2025
Drug Buyers, Generics Cos. Fight Over Bellwether Litigation
March 26, 2025
False COVID Cure Claims No Longer Feds' 'Current Priority'
March 20, 2025
Judge Won't Let Meijer Appeal Takeda's Arbitration Mandate
March 11, 2025
Trump Admin Drops Suit Over COVID Nasal Spray Ads Claims
March 03, 2025
Teva Should Face Key Copaxone Antitrust Claims, Court Told
March 03, 2025
Sutter Settles Years-Old Antitrust Suit On Courthouse Steps
February 25, 2025
FTC Probing $615M Healthcare Staffing Merger
February 24, 2025
PBMs To Challenge FTC Case At 8th Circ., But Without Pause
February 19, 2025
Judge Won't Halt PBM Case Over Attack On FTC Independence